4//SEC Filing
Kirby John J. 4
Accession 0001415889-22-003753
CIK 0000861838other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:45 PM ET
Size
5.6 KB
Accession
0001415889-22-003753
Insider Transaction Report
Form 4
Kirby John J.
V.P. of Finance, PFO & PAO
Transactions
- Award
Stock Option (Right to Buy)
2022-04-01+41,500→ 41,500 totalExercise: $0.54Exp: 2032-04-01→ Common Stock (41,500 underlying)
Footnotes (1)
- [F1]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option will vest and become exercisable in full on January 24, 2026, with 25% vesting on January 24, 2023, and the remainder vesting in twelve equal quarterly installments over the remaining three years, subject to continued service with the Issuer.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001556327
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:45 PM ET
- Size
- 5.6 KB